Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT - UTU Tutkimustietojärjestelmä

A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Tekijät: Donal P. McLornan, Richard Szydlo, Marie Robin, Anja van Biezen, Linda Koster, Henrik J. P. Blok, Maria T. Van Lint, Jürgen Finke, Antonin Vitek, Kristina Carlson, Laimonas Griskevicius, Ernst Holler, Maija Itälä-Remes, Michel Schaap, Gerard Socié, Jacques-Olivier Bay, Yves Beguin, Benedetto Bruno, Jan J. Cornelissen, Tobias Gedde-Dahl, Per Ljungman, Marie T. Rubio, Ibrahim Yakoub-Agha, Evgeny Klyuchnikov, Eduardo Olavarria, Yves Chalandon, Nicolaus Kröger

Kustantaja: WILEY

Julkaisuvuosi: 2018

Journal: British Journal of Haematology

Tietokannassa oleva lehden nimi: BRITISH JOURNAL OF HAEMATOLOGY

Lehden akronyymi: BRIT J HAEMATOL

Vuosikerta: 182

Numero: 3

Aloitussivu: 418

Lopetussivu: 422

Sivujen määrä: 5

ISSN: 0007-1048

eISSN: 1365-2141

DOI: https://doi.org/10.1111/bjh.15407

Tiivistelmä

Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.